Stayble Therapeutics AB (publ) (STO:STABL)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.3000
-0.0040 (-1.32%)
Sep 15, 2025, 4:24 PM CET

Stayble Therapeutics AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Selling, General & Admin
9.413.032424.9512.1414.98
Upgrade
Other Operating Expenses
-0.03---0-0-
Upgrade
Operating Expenses
9.5113.1824.124.9512.1414.98
Upgrade
Operating Income
-9.51-13.18-24.1-24.95-12.14-14.98
Upgrade
Interest Expense
-0.05-0.05-0.04-0.03-0.06-0.4
Upgrade
Interest & Investment Income
0.230.430.260.030.03-
Upgrade
Currency Exchange Gain (Loss)
---0.420.08-0.11
Upgrade
Other Non Operating Income (Expenses)
0.070.390.15---
Upgrade
Pretax Income
-9.27-12.42-23.74-24.53-12.09-15.49
Upgrade
Net Income
-9.27-12.42-23.74-24.53-12.09-15.49
Upgrade
Net Income to Common
-9.27-12.42-23.74-24.53-12.09-15.49
Upgrade
Shares Outstanding (Basic)
48382614147
Upgrade
Shares Outstanding (Diluted)
48382614147
Upgrade
Shares Change (YoY)
49.70%47.05%86.06%-100.00%70.26%
Upgrade
EPS (Basic)
-0.19-0.33-0.92-1.77-0.87-2.24
Upgrade
EPS (Diluted)
-0.19-0.33-0.92-1.77-0.87-2.24
Upgrade
EBITDA
--13.03-24---
Upgrade
D&A For EBITDA
-0.150.1---
Upgrade
EBIT
-9.51-13.18-24.1-24.95-12.14-14.98
Upgrade
Revenue as Reported
0.070.390.150.290.010.08
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.